About Catalyst Pharmaceuticals

What does Catalyst Pharmaceuticals do?

Catalyst Pharmaceuticals is a provider of prescription drug development and commercialization, offering FIRDAPSE (FDA-approved for adults with Lambert-Eaton myasthenic syndrome) and FYCOMPA (for partial-onset seizures in individuals 4+ and primary generalized tonic-clonic seizures in those 12+). Supports investigator-sponsored research in LEMS and hereditary neuropathy and provides a U.S. expanded access program offering its lead product at no charge prior to FDA approval.

Who are Catalyst Pharmaceuticals's competitors?

Catalyst Pharmaceuticals's competitors and similar companies include HMNC Brain Health, SyntheticMR, Liftware, AC Immune, and Magnus Medical.

Where is Catalyst Pharmaceuticals headquartered?

Catalyst Pharmaceuticals is headquartered in United States.

How many employees does Catalyst Pharmaceuticals have?

Catalyst Pharmaceuticals has 1,000 employees 🔒.

When was Catalyst Pharmaceuticals founded?

Catalyst Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Catalyst Pharmaceuticals in?

Catalyst Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Catalyst Pharmaceuticals

Who are the top strategic acquirers in Catalyst Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Catalyst Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Catalyst Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Catalyst Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Catalyst Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Catalyst Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Catalyst Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Catalyst Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Catalyst Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Catalyst Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Catalyst Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Catalyst Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Catalyst Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Catalyst Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Catalyst Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Catalyst Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Catalyst Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Catalyst Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Catalyst Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Catalyst Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.